Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

BCTXBriaCell Therapeutics Corp.

Nasdaq · CIK 0001610820
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end0731
XBRL facts278

Identity from submissions API

NameBriaCell Therapeutics Corp.
CIK0001610820
TickersBCTX, BCTXL, BCTXZ
ExchangesNasdaq, Nasdaq, Nasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN000000000
LEI—
Fiscal year end0731
State of incorporationA1 British Columbia, Canada
Phone(604) 921-1810
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Ansell Capital Corp. (2014-06-20T04:00:00.000Z → 2014-06-20T04:00:00.000Z)
Business address
3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR
WEST VANCOUVER
A1
V7T 2X1
British Columbia, Canada
Mailing address
3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR
WEST VANCOUVER
A1
V7T 2X1
British Columbia, Canada

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

No Financialist filing articles yet for this CIK.

SEC filings

324 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-10-28 10-K 10-K 0001493152-26-049041 001-40101 261496395 34 13479960 1 1
2026-06-26 8-K 8-K 7.01,9.01 0001493152-26-030286 001-40101 261129027 34 1689214 1 1
2026-06-09 10-Q 10-Q 0001493152-26-027928 001-40101 261076098 34 7084822 1 1
2026-06-03 8-K 8-K 1.01,3.02,8.01,9.01 0001493152-26-026953 001-40101 261058694 34 1012897 1 1
2026-06-02 424B5 424B5 0001493152-26-026759 333-276650 261053658 33 882653
2026-03-31 8-K 8-K 7.01,9.01 0001493152-26-014156 001-40101 26821820 34 1999677 1 1
2026-03-10 10-Q 10-Q 0001493152-26-009557 001-40101 26740380 34 7230854 1 1
2026-03-09 8-K 8-K 5.07 0001493152-26-009382 001-40101 26735861 34 269435 1 1
2026-02-26 25-NSE xslF25X02/primary_doc.xml 0001354457-26-000220 001-40101 26685961 34 3151
2026-02-20 8-K 8-K 8.01,9.01 0001493152-26-007587 001-40101 26659690 34 294439 1 1
2026-02-12 DEF 14A DEF 14A 0001493152-26-006390 001-40101 26626016 34 6735099 1 1
2026-01-23 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-26-006332 005-92289 26558119 34 27844
2026-01-15 8-K 8-K 1.01,8.01,9.01 0001493152-26-002430 001-40101 26536447 34 1616247 1 1
2026-01-14 424B4 424B4 0001493152-26-002258 333-292388 26533472 33 402481
2026-01-13 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000157 333-292388 26531384 33 1872
2026-01-13 S-1MEF S-1MEF 0001493152-26-002103 333-292716 26531299 33 362862 1 1
2026-01-13 CERT BCTXL_8-A_Cert_1610820.pdf 0001354457-26-000037 001-40101 26530797 34 120642
2026-01-13 8-A12B 8-A12B 0001493152-26-001969 001-40101 26529103 34 401688
2026-01-08 CORRESP filename1.htm 0001493152-26-000962 12879
2026-01-08 CORRESP filename1.htm 0001493152-26-000961 11327
2026-01-06 CORRESP filename1.htm 0001493152-26-000535 11543
2026-01-06 CORRESP filename1.htm 0001493152-26-000533 10448
2025-12-29 8-K 8-K 7.01,9.01 0001493152-25-029363 001-40101 251609170 34 1146391 1 1
2025-12-23 FWP FWP 0001493152-25-028923 333-292388 251595358 34 48304291
2025-12-23 S-1 S-1 0001493152-25-028916 333-292388 251594896 33 2243238 1 1
2025-12-11 10-Q 10-Q 0001493152-25-027240 001-40101 251565017 34 5903390 1 1
2025-12-01 8-K 8-K 7.01,9.01 0001493152-25-025469 001-40101 251536930 34 1506229 1 1
2025-11-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001649553-25-000191 005-92289 251463337 34 11810
2025-10-16 DRSLTR filename1.htm 0001493152-25-018318 10050
2025-10-16 DRS filename1.htm 0001493152-25-018316 377-08574 251397854 33 589357
2025-10-16 10-K 10-K 0001493152-25-018212 001-40101 251396232 34 12587217 1 1
2025-10-10 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002090655-25-000002 005-92289 251387066 34 9348
2025-08-26 8-K 8-K 8.01,9.01 0001641172-25-025438 001-40101 251252409 34 276147 1 1
2025-08-01 S-8 S-8 0001641172-25-021790 333-289157 251173251 33 306805 1 1
2025-07-28 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000930413-25-002258 005-92289 251154318 34 18215
2025-07-22 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001649553-25-000130 005-92289 251138938 34 15378
2025-07-21 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001649553-25-000125 005-92289 251136219 34 11854
2025-07-16 8-K 8-K 1.01,8.01,9.01 0001641172-25-019892 001-40101 251127632 34 1082677 1 1
2025-07-16 424B4 424B4 0001641172-25-019807 333-288562 251126074 33 996791
2025-07-15 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002260 333-288562 251126103 33 1873
2025-07-15 CORRESP filename1.htm 0001641172-25-019660 11279
2025-07-15 CORRESP filename1.htm 0001641172-25-019658 12483
2025-07-14 CORRESP filename1.htm 0001641172-25-019540 12485
2025-07-14 CORRESP filename1.htm 0001641172-25-019539 11281
2025-07-11 CORRESP filename1.htm 0001641172-25-018739 12108
2025-07-11 CORRESP filename1.htm 0001641172-25-018738 11440
2025-07-11 FWP FWP 0001641172-25-018644 333-288562 251117207 34 18023703
2025-07-10 S-1/A S-1/A 0001641172-25-018633 333-288562 251117099 33 2267609 1 1
2025-07-09 S-1/A S-1/A 0001641172-25-018347 333-288562 251112920 33 1173575
2025-07-08 FWP FWP 0001641172-25-018224 333-288562 251111481 34 18887827
2025-07-08 CORRESP filename1.htm 0001641172-25-018221 11871
2025-07-08 CORRESP filename1.htm 0001641172-25-018220 9935
2025-07-08 S-1 S-1 0001641172-25-018193 333-288562 251111140 33 2517921 1 1
2025-06-24 UPLOAD filename1.pdf 0000000000-25-006592 377-08120 40476
2025-06-18 DRSLTR filename1.htm 0001641172-25-015610 10803
2025-06-18 DRS filename1.htm 0001641172-25-015605 377-08120 251057616 33 1140458
2025-06-18 8-K 8-K 7.01,9.01 0001641172-25-015516 001-40101 251055223 34 1181763 1 1
2025-06-16 10-Q 10-Q 0001641172-25-015265 001-40101 251050674 34 7889599 1 1
2025-05-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001753926-25-000802 005-92289 25942290 34 15617
2025-05-01 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001649553-25-000062 005-92289 25900120 34 15250
2025-04-28 8-K form8-k.htm 1.01,8.01,9.01 0001641172-25-006428 001-40101 25880544 34 1600569 1 1
2025-04-28 424B4 form424b4.htm 0001641172-25-006361 333-286735 25876349 33 919265
2025-04-28 424B4 form424b4.htm 0001641172-25-006359 333-286670 25876342 33 919265
2025-04-24 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-001243 333-286670 25869720 33 1872
2025-04-24 S-1MEF forms-1mef.htm 0001641172-25-006036 333-286735 25868867 33 147305
2025-04-24 CERT BCTXZ_8-A_Cert.pdf 0001354457-25-000352 001-40101 25868224 34 128772
2025-04-24 8-A12B form8a12b.htm 0001641172-25-005992 001-40101 25867048 34 341159
2025-04-23 S-1/A forms-1a.htm 0001641172-25-005871 333-286670 25862239 33 1393692
2025-04-22 FWP formfwp.htm 0001641172-25-005700 333-286670 25858039 34 11401876
2025-04-22 CORRESP filename1.htm 0001641172-25-005685 14037
2025-04-22 CORRESP filename1.htm 0001641172-25-005681 9985
2025-04-22 CORRESP filename1.htm 0001641172-25-005678 17012
2025-04-22 S-1 forms-1.htm 0001641172-25-005677 333-286670 25857666 33 2277782
2025-03-24 UPLOAD filename1.pdf 0000000000-25-003111 377-07783 44771
2025-03-12 DRSLTR filename1.htm 0001493152-25-010079 9191
2025-03-12 DRS filename1.htm 0001493152-25-010077 377-07783 25732573 33 3043995
2025-03-12 10-Q form10-q.htm 0001493152-25-010052 001-40101 25732044 34 6295747 1 1
2025-03-12 8-K form8-k.htm 7.01,9.01 0001493152-25-010035 001-40101 25731633 34 1142574 1 1
2025-02-13 8-K form8-k.htm 8.01 0001493152-25-006419 001-40101 25619979 34 259952 1 1
2025-02-10 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001753926-25-000202 005-92289 25607397 34 24392
2025-02-06 8-K form8-k.htm 5.07 0001493152-25-005204 001-40101 25597817 34 290284 1 1
2025-02-05 8-K form8-k.htm 1.01,3.02,8.01,9.01 0001493152-25-005043 001-40101 25594217 34 1251169 1 1
2025-02-04 424B5 form424b5.htm 0001493152-25-004856 333-276650 25588129 33 1055561
2025-02-03 424B5 form424b5.htm 0001493152-25-004684 333-276650 25583107 33 1052842
2025-01-28 8-K form8-k.htm 8.01,9.01 0001493152-25-003977 001-40101 25564043 34 305876 1 1
2025-01-03 8-K form8-k.htm 8.01,9.01 0001493152-25-000282 001-40101 25507501 34 310866 1 1
2025-01-03 8-K form8-k.htm 8.01,9.01 0001493152-25-000281 001-40101 25507500 34 300900 1 1
2025-01-03 DEFA14A formdefa14a.htm 0001493152-25-000283 001-40101 25507496 34 848918
2024-12-17 DEF 14A formdef14a.htm 0001493152-24-050399 001-40101 241555654 34 2145747
2024-12-16 10-Q form10-q.htm 0001493152-24-050214 001-40101 241551821 34 6004239 1 1
2024-12-16 8-K form8-k.htm 7.01,9.01 0001493152-24-050212 001-40101 241551815 34 1024623 1 1
2024-12-13 8-K form8-k.htm 1.01,3.02,8.01,9.01 0001493152-24-049999 001-40101 241548558 34 1648718 1 1
2024-12-12 424B5 form424b5.htm 0001493152-24-049831 333-276650 241546071 33 691247
2024-12-12 SC 13D/A formsc13da.htm 0001493152-24-049719 005-92289 241543134 34 90487
2024-12-11 424B5 form424b5.htm 0001493152-24-049661 333-276650 241542453 33 699924
2024-12-10 SC 13D/A formsc13da.htm 0001493152-24-049352 005-92289 241537032 34 88986
2024-12-05 SC 13D/A formsc13da.htm 0001493152-24-048801 005-92289 241527849 34 87470
2024-11-25 8-K form8-k.htm 5.02 0001493152-24-047606 001-40101 241495781 34 261558 1 1
2024-11-14 SC 13G/A SC 13G/A 0001104659-24-118625 005-92289 241459271 34 62563
2024-11-01 8-K form8-k.htm 7.01,9.01 0001493152-24-043322 001-40101 241419068 34 1192977 1 1
2024-10-29 10-K form10-k.htm 0001493152-24-042743 001-40101 241402194 34 11725154 1 1
2024-10-02 8-K form8-k.htm 1.01,8.01,9.01 0001493152-24-039218 001-40101 241347892 34 1723667 1 1
2024-10-02 424B5 form424b5.htm 0001493152-24-039136 333-276650 241345614 33 675548
2024-10-01 8-K form8-k.htm 8.01,9.01 0001493152-24-039016 001-40101 241343174 34 617520 1 1
2024-09-16 SC 13G SC 13G 0001104659-24-100052 005-92289 241299896 34 72133
2024-09-12 8-K form8-k.htm 1.01,3.02,8.01,9.01 0001493152-24-036055 001-40101 241295254 34 1426788 1 1
2024-09-12 424B5 form424b5.htm 0001493152-24-035877 333-276650 241293597 33 803776
2024-09-11 8-K form8-k.htm 8.01,9.01 0001493152-24-035737 001-40101 241291500 34 371882 1 1
2024-08-23 8-K form8-k.htm 3.01 0001493152-24-033753 001-40101 241237080 34 257780 1 1
2024-07-18 8-K form8-k.htm 7.01,9.01 0001493152-24-028343 001-40101 241125109 34 373049 1 1
2024-07-05 8-K form8-k.htm 3.01 0001493152-24-026349 001-40101 241102716 34 257306 1 1
2024-06-14 10-Q form10-q.htm 0001493152-24-023867 001-40101 241044852 34 4864290 1 1
2024-06-14 8-K form8-k.htm 7.01,9.01 0001493152-24-023860 001-40101 241044687 34 999745 1 1
2024-05-24 SC 13D/A formsc13da.htm 0001493152-24-021272 005-92289 24981121 34 83474
2024-05-20 4 xslF345X05/ownership.xml 0001493152-24-020660 7750
2024-05-17 8-K form8-k.htm 1.01,8.01,9.01 0001493152-24-020460 001-40101 24960754 34 1334212 1 1
2024-05-16 424B5 form424b5.htm 0001493152-24-020290 333-276650 24956663 33 510047
2024-04-02 8-K form8-k.htm 7.01,9.01 0001493152-24-012774 001-40101 24814184 34 1010117 1 1
2024-03-18 10-Q form10-q.htm 0001493152-24-010354 001-40101 24760052 34 4584522 1 1
2024-01-31 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-01-31 17:00:00 9999999995-24-000271 333-276650 24584885 33 1879
2024-01-31 8-K form8-k.htm 5.07 0001493152-24-004525 001-40101 24584012 34 282723 1 1
2024-01-29 CORRESP filename1.htm 0001493152-24-004142 10570
2024-01-29 UPLOAD filename1.pdf 0000000000-24-001087 333-276650 40460
2024-01-22 S-3 forms-3.htm 0001493152-24-003291 333-276650 24549553 33 485470
2024-01-09 DEF 14A formdef14a.htm 0001493152-24-001830 001-40101 24523291 34 2277593
2024-01-08 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001718996-24-000001 005-92289 24518884 34 6773
2023-12-20 8-K form8-k.htm 8.01,9.01 0001493152-23-045569 001-40101 231501379 34 307257 1 1
2023-12-14 10-Q form10-q.htm 0001493152-23-044892 001-40101 231487795 34 3980088 1 1
2023-12-14 8-K form8-k.htm 7.01,9.01 0001493152-23-044891 001-40101 231487791 34 943385 1 1
2023-11-30 8-K form8-k.htm 7.01,9.01 0001493152-23-043142 001-40101 231453953 34 289516 1 1
2023-11-03 8-K form8-k.htm 7.01,9.01 0001493152-23-039228 001-40101 231374601 34 348373 1 1
2023-10-25 10-K form10-k.htm 0001493152-23-038298 001-40101 231346919 34 8475075 1 1
2023-10-25 8-K form8-k.htm 7.01,9.01 0001493152-23-038297 001-40101 231346909 34 14455317 1 1
2023-09-08 8-K form8-k.htm 7.01,9.01 0001493152-23-032041 001-40101 231243746 34 290248 1 1
2023-09-07 8-K form8-k.htm 5.03,9.01 0001493152-23-031982 001-40101 231242649 34 2342585 1 1
2023-08-31 8-K form8-k.htm 8.01,9.01 0001493152-23-031061 001-40101 231229975 34 289665 1 1
2023-08-31 8-K form8-k.htm 8.01,9.01 0001493152-23-031359 001-40101 231229801 34 289665 1 1
2023-08-25 8-K form8-k.htm 8.01,9.01 0001493152-23-030245 001-40101 231209052 34 291456 1 1
2023-08-21 8-K form8-k.htm 5.07,8.01,9.01 0001493152-23-029604 001-40101 231189159 34 324205 1 1
2023-07-26 DEF 14A formdef14a.htm 0001493152-23-025573 001-40101 231113493 34 11054004
2023-06-30 PRE 14A formpre14a.htm 0001493152-23-023136 001-40101 231062173 34 5332370
2023-06-27 8-K form8-k.htm 7.01,9.01 0001493152-23-022575 001-40101 231044441 34 294619 1 1
2023-06-14 10-Q form10-q.htm 0001493152-23-021287 001-40101 231015051 34 5220883 1 1
2023-05-31 8-K form8-k.htm 1.01,7.01,9.01 0001493152-23-019652 001-40101 23981407 34 757602 1 1
2023-05-22 8-K form8-k.htm 3.02,9.01 0001493152-23-018481 001-40101 23943171 34 297041 1 1
2023-05-15 8-K form8-k.htm 1.01,9.01 0001493152-23-017363 001-40101 23922552 34 544069 1 1
2023-04-17 8-K form8-k.htm 7.01,9.01 0001493152-23-012566 001-40101 23824509 34 7460665 1 1
2023-03-30 8-K form8-k.htm 7.01,9.01 0001493152-23-009816 001-40101 23781588 34 309514 1 1
2023-03-28 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001493152-23-008251,2023-03-28 9999999995-23-000686 333-234292 23771584 33 1843
2023-03-20 POS AM formposam.htm 0001493152-23-008251 333-234292 23746690 33 244443
2023-03-16 UPLOAD filename1.pdf 0000000000-23-002624 39795
2023-03-16 10-Q form10-q.htm 0001493152-23-007796 001-40101 23736484 34 5065543 1 1
2023-03-13 CORRESP filename1.htm 0001493152-23-007488 68211
2023-03-08 UPLOAD filename1.pdf 0000000000-23-002277 43919
2023-02-23 8-K form8-k.htm 7.01,9.01 0001493152-23-005827 001-40101 23656016 34 292098 1 1
2023-02-15 8-K form8-k.htm 5.03,5.07,9.01 0001493152-23-005199 001-40101 23635309 34 308028 1 1
2023-02-14 SC 13G/A SC 13G/A 0001104659-23-021743 005-92289 23630398 34 69516
2023-02-10 8-K form8-k.htm 8.01,9.01 0001493152-23-004295 001-40101 23612539 34 300202 1 1
2023-01-24 8-K form8-k.htm 7.01,9.01 0001493152-23-002354 001-40101 23549010 34 310095 1 1
2023-01-23 8-K form8-k.htm 7.01,9.01 0001493152-23-002198 001-40101 23544608 34 290083 1 1
2023-01-18 8-K form8-k.htm 7.01,9.01 0001493152-23-001731 001-40101 23533031 34 296199 1 1
2023-01-17 DEF 14A formdef14a.htm 0001493152-23-001505 001-40101 23530051 34 2508183
2023-01-10 8-K form8-k.htm 7.01,9.01 0001493152-23-001049 001-40101 23520165 34 302894 1 1
2023-01-05 PRE 14A formpre14a.htm 0001493152-23-000443 001-40101 23509836 34 4844955
2022-12-28 4 xslF345X03/ownership.xml 0001493152-22-036669 4556
2022-12-28 4 xslF345X03/ownership.xml 0001493152-22-036643 5860
2022-12-20 4 xslF345X03/ownership.xml 0001493152-22-036060 4548
2022-12-14 10-Q form10-q.htm 0001493152-22-035452 001-40101 221462694 34 3477686 1 1
2022-12-08 8-K form8-k.htm 7.01,9.01 0001493152-22-034831 001-40101 221451546 34 9879763 1 1
2022-11-30 8-K form8-k.htm 7.01,9.01 0001493152-22-034020 001-40101 221435561 34 317161 1 1
2022-11-10 8-K form8-k.htm 7.01,9.01 0001493152-22-031250 001-40101 221375213 34 4946805 1 1
2022-10-28 10-K form10-k.htm 0001493152-22-029742 001-40101 221338443 34 9205209 1 1
2022-10-28 8-K form8-k.htm 2.02,7.01,8.01,9.01 0001493152-22-029741 001-40101 221338439 34 3447868 1 1
2022-10-21 8-K form8-k.htm 7.01,9.01 0001493152-22-029278 001-40101 221322279 34 296173 1 1
2022-09-14 8-K form8-k.htm 7.01,9.01 0001493152-22-025861 001-40101 221243066 34 285637 1 1
2022-08-11 3 xslF345X02/ownership.xml 0001493152-22-022149 7772
2022-08-04 8-K form8-k.htm 1.01,9.01 0001493152-22-021361 001-40101 221137687 34 548150 1 1
2022-08-02 3 xslF345X02/ownership.xml 0001493152-22-021000 5092
2022-08-01 3 xslF345X02/ownership.xml 0001493152-22-020881 4216
2022-08-01 3 xslF345X02/ownership.xml 0001493152-22-020884 5176
2022-08-01 3 xslF345X02/ownership.xml 0001493152-22-020883 4232
2022-08-01 3 xslF345X02/ownership.xml 0001493152-22-020882 5821
2022-08-01 3 xslF345X02/ownership.xml 0001493152-22-020877 6160
2022-08-01 3 xslF345X02/ownership.xml 0001493152-22-020879 6812
2022-08-01 3 xslF345X02/ownership.xml 0001493152-22-020880 5169
2022-08-01 3 xslF345X02/ownership.xml 0001493152-22-020878 5798
2022-08-01 SC 13G SC 13G 0001104659-22-084430 005-92289 221122704 34 80531
2022-07-18 6-K form6-k.htm 0001493152-22-019531 001-40101 221088135 34 325265
2022-07-05 6-K form6-k.htm 0001493152-22-018457 001-40101 221063330 34 53015
2022-06-29 6-K form6-k.htm 0001493152-22-018099 001-40101 221054719 34 49317
2022-06-24 6-K form6-k.htm 0001493152-22-017706 001-40101 221040046 34 51222
2022-06-13 6-K form6-k.htm 0001493152-22-016599 001-40101 221012634 34 5632058 1 1
2022-05-18 6-K form6-k.htm 0001493152-22-014317 001-40101 22939079 34 58537
2022-04-25 SC 13G formsc13g.htm 0001493152-22-010830 005-92289 22849711 34 65604
2022-04-13 6-K form6-k.htm 0001493152-22-009769 001-40101 22823688 34 62482
2022-04-12 6-K form6-k.htm 0001493152-22-009714 001-40101 22822840 34 61770
2022-04-07 6-K form6-k.htm 0001493152-22-009316 001-40101 22812380 34 62359
2022-03-21 424B3 form424b3.htm 0001493152-22-007358 333-257104 22755774 33 234121
2022-03-16 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001493152-22-006504,2022-03-16 9999999995-22-000649 333-257104 22746589 33 1843
2022-03-15 6-K form6-k.htm 0001493152-22-006886 001-40101 22741951 34 6245913 1 1
2022-03-10 POS AM formposam.htm 0001493152-22-006504 333-257104 22729058 33 460366
2022-02-28 6-K form6-k.htm 0001493152-22-005610 001-40101 22690178 34 49980
2022-02-23 6-K form6k.htm 0001493152-22-005232 001-40101 22663472 34 42968
2022-02-16 6-K form6-k.htm 0001493152-22-004803 001-40101 22644796 34 40333
2022-02-14 SC 13G/A SC 13G/A 0001104659-22-022532 005-92289 22630411 34 66421
2022-02-14 SC 13G/A AMENDMENT TO SC 13G 0001387131-22-001737 005-92289 22624100 34 84563
2022-02-14 SC 13G/A SC 13G/A 0001553350-22-000149 005-92289 22623159 34 45294
2022-02-11 SC 13G/A sc13g.htm 0000929638-22-000419 005-92289 22622415 34 68837
2022-02-11 SC 13G/A SC 13G/A 0001104659-22-019877 005-92289 22616802 34 53248
2022-02-10 6-K form6-k.htm 0001493152-22-003745 001-40101 22613885 34 46411
2022-02-04 SC 13G/A sc13ga110022002_02042022.htm 0000921895-22-000337 005-92289 22593974 34 207090
2022-01-20 SC 13G/A BRIACELL THERAPEUTICS CORP. 0000902664-22-000371 005-92289 22540963 34 74253
2022-01-20 6-K form6-k.htm 0001493152-22-001654 001-40101 22540556 34 66436
2022-01-05 6-K form6-k.htm 0001493152-22-000358 001-40101 22508617 34 2419608
2022-01-04 SC 13G/A SABBY 13G-A BCTX 1.03.22 0001535610-22-000014 005-92289 22503523 34 13373
2021-12-30 6-K form6-k.htm 0001493152-21-032819 001-40101 211532793 34 56169
2021-12-17 6-K form6-k.htm 0001493152-21-031750 001-40101 211498904 34 47174
2021-12-15 6-K form6-k.htm 0001493152-21-031513 001-40101 211493526 34 961010
2021-12-09 6-K form6-k.htm 0001493152-21-030957 001-40101 211481947 34 70351
2021-11-26 424B3 form-424b3.htm 0001493152-21-029898 333-234292 211449057 33 2938202
2021-11-23 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001493152-21-029260,2021-11-23 9999999995-21-004457 333-234292 211441076 33 1844
2021-11-19 POS AM formposam.htm 0001493152-21-029260 333-234292 211425809 33 11199702 1 1
2021-11-19 6-K form6-k.htm 0001493152-21-029259 001-40101 211425767 34 42686
2021-11-16 40-F/A form40-fa.htm 0001493152-21-028949 001-40101 211416075 34 8310976 1 1
2021-11-12 6-K form6-k.htm 0001493152-21-028211 001-40101 211404339 34 71299
2021-11-05 6-K form6-k.htm 0001493152-21-027353 001-40101 211384500 34 47649
2021-11-02 6-K form6-k.htm 0001493152-21-026978 001-40101 211371196 34 43515
2021-10-29 40-F form40-f.htm 0001493152-21-026729 001-40101 211363405 34 151650
2021-10-29 6-K form6-k.htm 0001493152-21-026724 001-40101 211363281 34 2582539
2021-10-18 424B3 form424b3.htm 0001493152-21-025689 333-257104 211328337 33 28667
2021-10-05 6-K form6-k.htm 0001493152-21-024627 001-40101 211306648 34 42435
2021-09-22 6-K form6-k.htm 0001493152-21-023360 001-40101 211269669 34 38373
2021-09-20 SC 13D/A AMENDMENT NO. 1 0001214659-21-009658 005-92289 211264129 34 53583
2021-09-13 SC 13G formsc13g.htm 0001493152-21-022504 005-92289 211248706 34 83132
2021-09-09 6-K form6-k.htm 0001493152-21-022296 001-40101 211244441 34 39234
2021-09-07 SC 13D formsc13d.htm 0001493152-21-022097 005-92289 211239342 34 100156
2021-09-01 6-K form6-k.htm 0001493152-21-021757 001-40101 211229435 34 47614
2021-08-23 6-K form6-k.htm 0001493152-21-020980 001-40101 211196571 34 79968
2021-08-19 6-K form6-k.htm 0001493152-21-020655 001-40101 211188771 34 41971
2021-08-17 SC 13G SC 13G 0001104659-21-107003 005-92289 211182794 34 62064
2021-08-17 6-K form6-k.htm 0001493152-21-020421 001-40101 211182540 34 18245
2021-08-13 6-K form6-k.htm 0001493152-21-019567 001-40101 211168993 34 147710
2021-08-09 SC 13D d87210sc13d.htm 0001214659-21-008231 005-92289 211154473 34 63107
2021-08-04 SC 13G/A sc13ga.htm 0001493152-21-018514 005-92289 211142617 34 108265
2021-07-14 6-K form6-k.htm 0001493152-21-016843 001-40101 211090285 34 43437
2021-07-12 6-K form6-k.htm 0001493152-21-016629 001-40101 211085596 34 85657
2021-07-08 6-K form6-k.htm 0001493152-21-016474 001-40101 211080863 34 193157
2021-06-30 6-K form6-k.htm 0001493152-21-015716 001-40101 211061973 34 1173174
2021-06-28 SC 13G sc13g.htm 0001493152-21-015372 005-92289 211053549 34 122454
2021-06-25 424B3 form424b3.htm 0001493152-21-015234 333-257104 211044906 33 6344746
2021-06-24 EFFECT xslEFFECTX01/primary_doc.xml F-1,,2021-06-24 17:00:00 9999999995-21-002511 333-257104 211044569 33 1831
2021-06-22 CORRESP filename1.htm 0001493152-21-014996 9578
2021-06-21 UPLOAD filename1.pdf 0000000000-21-007591 40395
2021-06-16 6-K form6-k.htm 0001493152-21-014535 001-40101 211021501 34 85831
2021-06-15 D xslFormDX01/primary_doc.xml 06b 0001493152-21-014435 021-403035 211019556 33 11521
2021-06-15 F-1 formf-1.htm 0001493152-21-014365 333-257104 211016813 33 12346298 1
2021-06-14 SC 13G SC 13G 0001104659-21-080647 005-92289 211014035 34 77837
2021-06-10 6-K form6-k.htm 0001493152-21-014014 001-40101 211008026 34 71599
2021-06-09 6-K form6-k.htm 0001493152-21-013903 001-40101 211005182 34 79018
2021-06-08 6-K form6-k.htm 0001493152-21-013786 001-40101 211001335 34 39900
2021-06-04 6-K form6-k.htm 0001493152-21-013659 001-40101 21997504 34 1018807
2021-06-02 6-K form6-k.htm 0001493152-21-013395 001-40101 21987750 34 120461
2021-05-20 6-K form6-k.htm 0001493152-21-012289 001-40101 21941739 34 108381
2021-05-11 6-K form6-k.htm 0001493152-21-011017 001-40101 21911235 34 55813
2021-04-27 6-K form6-k.htm 0001493152-21-009850 001-40101 21859374 34 447162
2021-04-16 6-K form6-k.htm 0001493152-21-009020 001-40101 21831879 34 53517
2021-04-12 6-K form6-k.htm 0001493152-21-008530 001-40101 21820568 34 64300
2021-04-01 6-K form6-k.htm 0001493152-21-007640 001-40101 21796028 34 951813
2021-03-31 6-K form6-k.htm 0001493152-21-007438 001-40101 21793250 34 56469
2021-03-08 SC 13G ACQUISITION OF BENEFICIAL OWNERSHIP 0001387131-21-003307 005-92289 21722167 34 86016
2021-03-05 SC 13G l1cap_scd13g.htm 0001079973-21-000150 005-92289 21718630 34 46264
2021-03-03 SC 13G SABBY 13G BCTX 0001535610-21-000082 005-92289 21707241 34 13349
2021-03-02 SC 13G BRIACELL THERAPEUTICS CORP. 0000902664-21-001692 005-92289 21702081 34 81023
2021-03-02 6-K form6-k.htm 0001493152-21-005141 001-40101 21700745 34 96258
2021-02-26 SC 13G sc13g.htm 0000929638-21-000414 005-92289 21690623 34 82073
2021-02-26 SC 13G sc13g10022bctxf_02262021.htm 0000921895-21-000562 005-92289 21684065 34 228463
2021-02-26 424B4 form424b4.htm 0001493152-21-004866 333-234292 21683667 33 4649026
2021-02-25 424B4 form424b4.htm 0001493152-21-004840 333-234292 21681145 33 4861311
2021-02-23 EFFECT xslEFFECTX01/primary_doc.xml F-1,,2021-02-23 17:00:00 9999999995-21-000708 333-234292 21668340 33 1830
2021-02-23 CERT 8A_Cert_BCTX.pdf 0001354457-21-000260 001-40101 21664459 34 150879
2021-02-23 8-A12B form8a12b.htm 0001493152-21-004540 001-40101 21662924 34 24142
2021-02-18 CORRESP filename1.htm 0001493152-21-004277 26163
2021-02-18 CORRESP filename1.htm 0001493152-21-004276 12044
2021-02-18 CORRESP filename1.htm 0001493152-21-004275 12031
2021-02-18 F-1/A formf1a.htm 0001493152-21-004274 333-234292 21650124 33 5112937
2021-02-03 F-1/A formf1a.htm 0001493152-21-002440 333-234292 21584030 33 5103064
2021-02-02 CORRESP filename1.htm 0001493152-21-002441 22554
2021-02-01 UPLOAD filename1.pdf 0000000000-21-001190 43236
2021-01-15 F-1/A formf1a.htm 0001493152-21-001108 333-234292 21530393 33 4881036
2021-01-14 CORRESP filename1.htm 0001493152-21-001110 19736
2020-12-23 F-1/A formf1a.htm 0001493152-20-024156 333-234292 201409356 33 231355
2020-12-22 CORRESP filename1.htm 0001493152-20-024158 16370
2020-12-21 UPLOAD filename1.pdf 0000000000-20-012286 43713
2020-12-10 CORRESP filename1.htm 0001493152-20-023258 16352
2020-12-10 F-1/A formf1a.htm 0001493152-20-023253 333-234292 201380416 33 6659427
2020-10-23 UPLOAD filename1.pdf 0000000000-20-010041 43696
2020-10-20 CORRESP filename1.htm 0001493152-20-019648 18490
2020-10-20 F-1/A formf1a.htm 0001493152-20-019645 333-234292 201247417 33 5305563
2020-10-16 UPLOAD filename1.pdf 0000000000-20-009789 45451
2020-09-18 F-1/A formf1a.htm 0001493152-20-017990 333-234292 201182676 33 6137650
2020-05-27 CORRESP filename1.htm 0001493152-20-009943 12011
2020-05-27 F-1/A formf-1a.htm 0001493152-20-009927 333-234292 20916095 33 6806475
2020-05-18 F-1/A formf-1a.htm 0001493152-20-009237 333-234292 20887608 33 6510854
2020-05-15 CORRESP filename1.htm 0001493152-20-009239 12013
2020-03-13 CORRESP filename1.htm 0001493152-20-003913 50102
2020-03-13 F-1/A formf-1a.htm 0001493152-20-003911 333-234292 20713205 33 6471278
2020-03-09 UPLOAD filename1.pdf 0000000000-20-002083 54585
2020-02-21 F-1/A formf-1a.htm 0001493152-20-002799 333-234292 20637557 33 5335083
2020-01-23 F-1/A formf-1a.htm 0001493152-20-000985 333-234292 20542321 33 487676
2020-01-21 F-1/A formf-1a.htm 0001493152-20-000871 333-234292 20536814 33 5572134
2019-11-27 CORRESP filename1.htm 0001493152-19-018526 16445
2019-11-27 F-1/A formf-1a.htm 0001493152-19-018524 333-234292 191258375 33 12197281
2019-11-22 UPLOAD filename1.pdf 0000000000-19-015785 50146
2019-11-12 CORRESP filename1.htm 0001493152-19-016847 43908
2019-11-12 F-1/A formf-1a.htm 0001493152-19-016844 333-234292 191206608 33 5022027
2019-11-08 UPLOAD filename1.pdf 0000000000-19-015343 55493
2019-11-06 DEL AM delam.htm 0001493152-19-016531 333-234292 191195757 33 12921
2019-10-22 CORRESP filename1.htm 0001493152-19-015841 127117
2019-10-22 F-1 formf-1.htm 0001493152-19-015838 333-234292 191162310 33 14256310
2019-10-01 UPLOAD filename1.pdf 0000000000-19-014114 84012
2019-08-30 DRS filename1.htm 0001493152-19-013547 377-02815 191069397 33 13915488
2018-04-10 D xslFormDX01/primary_doc.xml 06b 0001009448-18-000001 021-309749 18747471 33 11716
2014-12-12 D xslFormDX01/primary_doc.xml 06b 0001140361-14-045152 021-230050 141284470 33 9028
2014-06-20 D xslFormDX01/primary_doc.xml 06b 0001140361-14-026175 021-219548 14931270 33 9584

Latest XBRL company facts

One latest value per concept from companyfacts (278 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 8.73M 2026-10-28 2026 FY 10-K 2026-10-28 0001493152-26-049041
dei EntityPublicFloat Entity Public Float USD 37.40M 2026-01-30 2026 FY 10-K 2026-10-28 0001493152-26-049041
ifrs-full AccountingProfit AccountingProfit USD -428,334 2020-08-01 2021-07-31 2021 FY 40-F/A 2021-11-16 0001493152-21-028949
ifrs-full AccumulatedOtherComprehensiveIncome AccumulatedOtherComprehensiveIncome USD -138,684 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full AdjustedWeightedAverageShares AdjustedWeightedAverageShares shares 4.52M 2020-08-01 2021-07-31 2021 FY 40-F/A 2021-11-16 0001493152-21-028949
ifrs-full AdjustmentsForDecreaseIncreaseInPrepaidExpenses AdjustmentsForDecreaseIncreaseInPrepaidExpenses USD -1.17M 2021-08-01 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full AdjustmentsForDecreaseIncreaseInTradeAccountReceivable AdjustmentsForDecreaseIncreaseInTradeAccountReceivable USD -1,958 2021-08-01 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full AdjustmentsForIncreaseDecreaseInDepositsFromBanks AdjustmentsForIncreaseDecreaseInDepositsFromBanks CAD 172,980 2019-07-30 2019-08-01 2021 FY 40-F/A 2021-11-16 0001493152-21-028949
ifrs-full AdjustmentsForIncreaseDecreaseInTradeAccountPayable AdjustmentsForIncreaseDecreaseInTradeAccountPayable USD -190,504 2021-08-01 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full AdjustmentsForInterestExpense AdjustmentsForInterestExpense USD 979 2021-08-01 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full AdjustmentsForSharebasedPayments AdjustmentsForSharebasedPayments USD 3.20M 2021-08-01 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full AdjustmentsForUnrealisedForeignExchangeLossesGains AdjustmentsForUnrealisedForeignExchangeLossesGains USD 884,536 2020-08-01 2021-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full AmortisationExpense AmortisationExpense USD 11,454 2021-08-01 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full AmortisationIntangibleAssetsOtherThanGoodwill AmortisationIntangibleAssetsOtherThanGoodwill USD 11,454 2021-08-01 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full ApplicableTaxRate ApplicableTaxRate pure 0.27 2020-08-03 2021-07-31 2021 FY 40-F/A 2021-11-16 0001493152-21-028949
ifrs-full Assets Assets USD 46.46M 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full BasicEarningsLossPerShare BasicEarningsLossPerShare USD/shares -0.72 2021-08-01 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full CashAndCashEquivalents CashAndCashEquivalents USD 44.53M 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full CashFlowsFromUsedInFinancingActivities CashFlowsFromUsedInFinancingActivities USD -3.58M 2021-08-01 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full CashFlowsFromUsedInInvestingActivities CashFlowsFromUsedInInvestingActivities CAD 1.34M 2019-07-30 2019-08-01 2021 FY 40-F/A 2021-11-16 0001493152-21-028949
ifrs-full CashFlowsFromUsedInOperatingActivities CashFlowsFromUsedInOperatingActivities USD -9.16M 2021-08-01 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full ComprehensiveIncome ComprehensiveIncome USD -11.09M 2021-08-01 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full CurrentAssets CurrentAssets USD 46.23M 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full CurrentLiabilities CurrentLiabilities USD 366,291 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full CurrentPrepaidExpenses CurrentPrepaidExpenses USD 1.68M 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full CurrentUnsecuredBankLoansReceivedAndCurrentPortionOfNoncurrentUnsecuredBankLoansReceived CurrentUnsecuredBankLoansReceivedAndCurrentPortionOfNoncurrentUnsecuredBankLoansReceived CAD 306,878 2020-07-31 2021 FY 40-F/A 2021-11-16 0001493152-21-028949
ifrs-full DeferredTaxAssets DeferredTaxAssets USD 59,332 2021-07-31 2021 FY 40-F/A 2021-11-16 0001493152-21-028949
ifrs-full DeferredTaxLiabilities DeferredTaxLiabilities USD 59,332 2021-07-31 2021 FY 40-F/A 2021-11-16 0001493152-21-028949
ifrs-full DepreciationAndAmortisationExpense DepreciationAndAmortisationExpense USD 11,454 2021-08-01 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full DirectorsRemunerationExpense DirectorsRemunerationExpense USD 2.22M 2021-08-01 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full EffectOfExchangeRateChangesOnCashAndCashEquivalents EffectOfExchangeRateChangesOnCashAndCashEquivalents USD -856,459 2020-08-01 2021-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full Equity Equity USD 45.82M 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full EquityAndLiabilities EquityAndLiabilities USD 46.46M 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full ExpenseFromSharebasedPaymentTransactionsWithEmployees ExpenseFromSharebasedPaymentTransactionsWithEmployees USD 3.20M 2021-08-01 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss USD -5,779 2021-08-01 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full GeneralAndAdministrativeExpense GeneralAndAdministrativeExpense USD 5.91M 2021-08-01 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full GovernmentGrants GovernmentGrants USD 25,986 2021-07-31 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full IncreaseDecreaseInCashAndCashEquivalents IncreaseDecreaseInCashAndCashEquivalents USD -12.74M 2021-08-01 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full IncreaseDecreaseThroughConversionOfConvertibleInstruments IncreaseDecreaseThroughConversionOfConvertibleInstruments USD 43,980 2020-08-01 2021-07-31 2021 FY 40-F/A 2021-11-16 0001493152-21-028949
ifrs-full IncreaseDecreaseThroughExerciseOfWarrantsEquity IncreaseDecreaseThroughExerciseOfWarrantsEquity USD 6.62M 2021-08-01 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full IncreaseDecreaseThroughTransfersAndOtherChangesIntangibleAssetsOtherThanGoodwill IncreaseDecreaseThroughTransfersAndOtherChangesIntangibleAssetsOtherThanGoodwill USD 0 2020-08-01 2021-07-31 2021 FY 40-F/A 2021-11-16 0001493152-21-028949
ifrs-full IntangibleAssetsOtherThanGoodwill IntangibleAssetsOtherThanGoodwill USD 234,156 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full InterestExpense InterestExpense USD 979 2021-08-01 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full InterestExpenseOnBorrowings InterestExpenseOnBorrowings USD 5,429 2020-08-01 2021-07-31 2021 FY 40-F/A 2021-11-16 0001493152-21-028949
ifrs-full InvestmentProperty InvestmentProperty USD 2 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full IssuedCapital IssuedCapital USD 55.85M 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full NoncurrentLiabilities NoncurrentLiabilities USD 278,396 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full NumberOfOutstandingShareOptions NumberOfOutstandingShareOptions shares 1.46M 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full NumberOfShareOptionsExercisableInSharebasedPaymentArrangement NumberOfShareOptionsExercisableInSharebasedPaymentArrangement shares 1.05M 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full NumberOfShareOptionsExpiredInSharebasedPaymentArrangement NumberOfShareOptionsExpiredInSharebasedPaymentArrangement shares 1,667 2021-08-01 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement shares 999 2021-08-01 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full NumberOfShareOptionsGrantedInSharebasedPaymentArrangement NumberOfShareOptionsGrantedInSharebasedPaymentArrangement shares 787,300 2021-08-01 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full NumberOfSharesIssued NumberOfSharesIssued shares 208,300 2022-01-31 2022 Q2 6-K 2022-03-15 0001493152-22-006886
ifrs-full OperatingExpense OperatingExpense USD 11.06M 2021-08-01 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation USD 53,235 2020-08-01 2021-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full PaymentsForShareIssueCosts PaymentsForShareIssueCosts USD 2.77M 2020-08-01 2021-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities USD 16,000 2021-08-01 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full ProceedsFromBorrowingsClassifiedAsFinancingActivities ProceedsFromBorrowingsClassifiedAsFinancingActivities USD 215,710 2020-08-01 2021-07-31 2021 FY 40-F/A 2021-11-16 0001493152-21-028949
ifrs-full ProceedsFromExerciseOfWarrants ProceedsFromExerciseOfWarrants USD 6.51M 2021-08-01 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full ProceedsFromIssueOfOrdinaryShares ProceedsFromIssueOfOrdinaryShares USD 26.93M 2020-08-01 2021-07-31 2021 FY 40-F/A 2021-11-16 0001493152-21-028949
ifrs-full ProceedsFromIssuingShares ProceedsFromIssuingShares USD 24.70M 2020-08-01 2021-07-31 2021 FY 40-F/A 2021-11-16 0001493152-21-028949
ifrs-full ProfessionalFeesExpense ProfessionalFeesExpense USD 76,627 2021-08-01 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full ProfitLoss ProfitLoss USD -11.09M 2021-08-01 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full ProfitLossFromOperatingActivities ProfitLossFromOperatingActivities USD -11.06M 2021-08-01 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full RentalExpense RentalExpense USD 8,600 2021-07-01 2021-07-31 2021 FY 40-F/A 2021-11-16 0001493152-21-028949
ifrs-full RepaymentsOfBorrowingsClassifiedAsFinancingActivities RepaymentsOfBorrowingsClassifiedAsFinancingActivities USD 23,577 2021-08-01 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full RepaymentsOfCurrentBorrowings RepaymentsOfCurrentBorrowings USD 274,000 2020-08-01 2021-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full ResearchAndDevelopmentExpense ResearchAndDevelopmentExpense USD 5.15M 2021-08-01 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full ReserveOfSharebasedPayments ReserveOfSharebasedPayments USD 5.36M 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full RetainedEarnings RetainedEarnings USD -27.58M 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full RevenueFromGovernmentGrants RevenueFromGovernmentGrants USD 3,388 2021-08-01 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full RevenueFromInterest RevenueFromInterest USD 54,373 2021-08-01 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full TaxEffectFromChangeInTaxRate TaxEffectFromChangeInTaxRate USD 5,893 2018-08-01 2019-07-31 2021 FY 40-F/A 2021-11-16 0001493152-21-028949
ifrs-full TaxEffectOfForeignTaxRates TaxEffectOfForeignTaxRates USD 30,180 2020-08-01 2021-07-31 2021 FY 40-F/A 2021-11-16 0001493152-21-028949
ifrs-full TaxExpenseIncomeAtApplicableTaxRate TaxExpenseIncomeAtApplicableTaxRate USD -115,650 2020-08-01 2021-07-31 2021 FY 40-F/A 2021-11-16 0001493152-21-028949
ifrs-full TradeAndOtherCurrentPayables TradeAndOtherCurrentPayables USD 366,291 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full TradeAndOtherCurrentReceivables TradeAndOtherCurrentReceivables USD 14,532 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full WagesAndSalaries WagesAndSalaries USD 790,349 2021-08-01 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full WarrantLiability WarrantLiability USD 278,396 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full WarrantReserve WarrantReserve USD 12.33M 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019 WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019 USD/shares -46.8 2021-08-01 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019 WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019 USD/shares 61.83 2020-08-01 2021-07-31 2021 FY 40-F/A 2021-11-16 0001493152-21-028949
ifrs-full WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019 WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019 USD/shares 5.74 2021-08-01 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 USD/shares 6.23 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
ifrs-full WeightedAverageShares WeightedAverageShares shares 15.49M 2021-08-01 2022-04-30 2022 Q3 6-K 2022-06-13 0001493152-22-016599
us-gaap AccountsPayableAndOtherAccruedLiabilitiesCurrent Accounts Payable and Other Accrued Liabilities, Current USD 987,109 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap AccountsPayableTradeCurrent Accounts Payable, Trade, Current USD 6.99M 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 15,233 2024-04-30 2024 Q3 10-Q 2024-06-14 0001493152-24-023867
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 657,718 2023-07-31 2023 FY 10-K 2023-10-25 0001493152-23-038298
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -138,684 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 7.92M 2023-10-31 2024 Q1 10-Q 2023-12-14 0001493152-23-044892
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 6.89M 2023-04-30 2023 Q3 10-Q 2023-06-14 0001493152-23-021287
us-gaap AdjustmentForAmortization Amortization USD 15,271 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD 20,251 2020-08-01 2021-07-31 2022 FY 10-K 2022-10-28 0001493152-22-029742
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD -199,207 2023-08-01 2024-07-31 2025 FY 10-K 2025-10-16 0001493152-25-018212
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 1.11M 2022-08-01 2022-10-31 2023 Q1 10-Q 2022-12-14 0001493152-22-035452
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition USD 1.74M 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 1.01M 2025-08-01 2026-04-30 2026 Q3 10-Q 2026-06-09 0001493152-26-027928
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 1.74M 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 15,271 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 10.05M 2021-08-01 2022-07-31 2022 FY 10-K 2022-10-28 0001493152-22-029742
us-gaap Assets Assets USD 23.58M 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap AssetsCurrent Assets, Current USD 22.04M 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 10.69M 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap AssetsNoncurrent Assets, Noncurrent USD 1.53M 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 9.85M 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 9.85M 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 13.65M 2023-10-31 2024 Q1 10-Q 2023-12-14 0001493152-23-044892
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -15.01M 2023-08-01 2024-01-31 2024 Q2 10-Q 2024-03-18 0001493152-24-010354
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -641,373 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 5.31 2023-04-30 2023 Q3 10-Q 2023-06-14 0001493152-23-021287
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 300 2023-04-30 2023 Q3 10-Q 2023-06-14 0001493152-23-021287
us-gaap CommonStockNoParValue Common Stock, No Par Value USD/shares 0 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2024-01-31 2024 Q2 10-Q 2024-03-18 0001493152-24-010354
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 8.71M 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 8.71M 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap CommonStockValue Common Stock, Value, Issued USD 120.91M 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -17.88M 2022-08-01 2023-04-30 2023 Q3 10-Q 2023-06-14 0001493152-23-021287
us-gaap ContractualObligation Contractual Obligation USD 2.90M 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 306,681 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 3.43M 2021-07-31 2022 FY 10-K 2022-10-28 0001493152-22-029742
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 35.38M 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 14.02M 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap DeferredTaxAssetsInvestmentInSubsidiaries Deferred Tax Assets, Investment in Subsidiaries USD 67,766 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 306,681 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 14.92M 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 79.43M 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsForeign Deferred Tax Assets, Operating Loss Carryforwards, Foreign USD 21.02M 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap DeferredTaxAssetsOtherLossCarryforwards Deferred Tax Assets, Other Loss Carryforwards USD 5.67M 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 731 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap DeferredTaxAssetsTaxDeferredExpense Deferred Tax Assets, Tax Deferred Expense USD 688,831 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 35.08M 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts Deferred Tax Liabilities, Deferred Expense, Debt Issuance Costs USD 7,750 2021-07-31 2022 FY 10-K 2022-10-28 0001493152-22-029742
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 56,755 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap Depreciation Depreciation USD 104,064 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 79,970 2024-08-01 2025-04-30 2025 Q3 10-Q 2025-06-16 0001641172-25-015265
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 11,453 2022-08-01 2023-04-30 2023 Q3 10-Q 2023-06-14 0001493152-23-021287
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 38,939 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -6.97 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -6.97 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.27 2024-08-01 2025-07-31 2025 FY 10-K 2025-10-16 0001493152-25-018212
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure 0.281 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0.051 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure 0.015 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.002 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure -0.15 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap EmployeeBenefitsAndShareBasedCompensationNoncash Employee Benefit and Share-based Payment Arrangement, Noncash USD 1.01M 2025-08-01 2026-04-30 2026 Q3 10-Q 2026-06-09 0001493152-26-027928
us-gaap EquityMethodInvestments Equity Method Investments USD 2 2023-07-31 2024 FY 10-K 2024-10-29 0001493152-24-042743
us-gaap EquitySecuritiesFVNINoncurrent EquitySecuritiesFVNINoncurrent USD 730,028 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap ExtinguishmentOfDebtAmount Extinguishment of Debt, Amount USD 79,717 2021-02-27 2021-03-01 2022 FY 10-K 2022-10-28 0001493152-22-029742
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD -298,734 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 135,876 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 153,984 2023-07-31 2023 FY 10-K 2023-10-25 0001493152-23-038298
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 15,271 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 15,271 2023-07-31 2023 FY 10-K 2023-10-25 0001493152-23-038298
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 15,271 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 15,271 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 15,271 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 305,130 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 169,254 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap FiniteLivedPatentsGross Finite-Lived Patents, Gross USD 305,130 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD -17,478 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD -166,937 2020-08-01 2021-07-31 2022 FY 10-K 2022-10-28 0001493152-22-029742
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 6.82M 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap GrantsReceivable Grants Receivable USD 1.12M 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap ImpairmentOfIntangibleAssetsFinitelived Impairment of Intangible Assets, Finite-lived USD 0 2021-08-01 2022-07-31 2022 FY 10-K 2022-10-28 0001493152-22-029742
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2021-08-01 2022-07-31 2022 FY 10-K 2022-10-28 0001493152-22-029742
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD 29.76M 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD 35.33M 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 5.57M 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap IncomeLossFromEquityMethodInvestments Income (Loss) from Equity Method Investments USD -263,477 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2021-07-01 2022-06-30 2022 FY 10-K 2022-10-28 0001493152-22-029742
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 9.94M 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 1.79M 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary Effective Income Tax Rate Reconciliation, Equity in Earnings (Losses) of Unconsolidated Subsidiary, Amount USD -15,420 2021-08-01 2022-07-31 2023 FY 10-K 2023-10-25 0001493152-23-038298
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 1.79M 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -5.30M 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD -9.54M 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD -7.17M 2024-08-01 2025-07-31 2025 FY 10-K 2025-10-16 0001493152-25-018212
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 531,294 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 81,843 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap IncomeTaxReconciliationRepatriationOfForeignEarnings Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount USD 7,810 2021-08-01 2022-07-31 2023 FY 10-K 2023-10-25 0001493152-23-038298
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 2.23M 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 3.71M 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap IncreaseDecreaseInAccountsPayableTrade Increase (Decrease) in Accounts Payable, Trade USD 5.30M 2023-08-01 2024-04-30 2024 Q3 10-Q 2024-06-14 0001493152-24-023867
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 3,246 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities Increase (Decrease) in Other Accounts Payable and Accrued Liabilities USD 292,824 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD -961,118 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 211,434 2023-08-01 2023-10-31 2025 Q1 10-Q 2024-12-16 0001493152-24-050214
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 169,254 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap IntangibleAssetsNetIncludingGoodwill Intangible Assets, Net (Including Goodwill) USD 173,072 2026-04-30 2026 Q3 10-Q 2026-06-09 0001493152-26-027928
us-gaap InterestAndDebtExpense Interest and Debt Expense USD 53,878 2020-08-01 2021-07-31 2022 FY 10-K 2022-10-28 0001493152-22-029742
us-gaap InterestExpense Interest Expense USD 979 2021-08-01 2022-07-31 2023 FY 10-K 2023-10-25 0001493152-23-038298
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 29,631 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 633,766 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 23.58M 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap LiabilitiesCurrent Liabilities, Current USD 7.98M 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap LiabilitiesFairValueDisclosure Financial and Nonfinancial Liabilities, Fair Value Disclosure USD 38,939 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 38,939 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap MinorityInterest Stockholders' Equity Attributable to Noncontrolling Interest USD -841,745 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 31.81M 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -3.81M 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -28.65M 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -34.90M 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap NetIncomeLossAttributableToNoncontrollingInterest Net Income (Loss) Attributable to Noncontrolling Interest USD -421,030 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -34.90M 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -5.80M 2024-08-01 2024-10-31 2025 Q1 10-Q 2024-12-16 0001493152-24-050214
us-gaap NoncurrentAssets Long-Lived Assets USD 215,068 2023-07-31 2023 FY 10-K 2023-10-25 0001493152-23-038298
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 601,461 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2022-08-01 2023-04-30 2023 Q3 10-Q 2023-06-14 0001493152-23-021287
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap NumberOfReportingUnits Number of Reporting Units Segment 1 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap OperatingExpenses Operating Expenses USD 36.05M 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -36.05M 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 26.41M 2024-07-31 2024 FY 10-K 2024-10-29 0001493152-24-042743
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 80,967 2021-07-31 2022 FY 10-K 2022-10-28 0001493152-22-029742
us-gaap OtherGeneralAndAdministrativeExpense Other General and Administrative Expense USD 409,197 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 101,062 2025-07-31 2025 FY 10-K 2025-10-16 0001493152-25-018212
us-gaap PaymentsForRepurchaseOfEquity Payments for Repurchase of Equity USD 47,294 2022-08-01 2023-07-31 2024 FY 10-K 2024-10-29 0001493152-24-042743
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 2.89M 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 377,000 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap PaymentsToAcquireOtherInvestments Payments to Acquire Other Investments USD 300,000 2022-08-01 2023-07-31 2024 FY 10-K 2024-10-29 0001493152-24-042743
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 127,049 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 24.59M 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap PreferredStockDividendsAndOtherAdjustments Preferred Stock Dividends and Other Adjustments USD -14.28M 2023-08-01 2023-10-31 2024 Q1 10-Q 2023-12-14 0001493152-23-044892
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 813,987 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap PrepaidExpenseNoncurrent Prepaid Expense, Noncurrent USD 315,703 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap ProceedsFromGrantors Proceeds from Grantors USD 936,363 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 26.93M 2020-08-01 2021-07-31 2022 FY 10-K 2022-10-28 0001493152-22-029742
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 31.81M 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 24.70M 2020-08-01 2021-07-31 2022 FY 10-K 2022-10-28 0001493152-22-029742
us-gaap ProceedsFromIssuanceOfUnsecuredDebt Proceeds from Issuance of Unsecured Debt USD 215,710 2020-08-01 2021-07-31 2022 FY 10-K 2022-10-28 0001493152-22-029742
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 50.90M 2025-08-01 2025-10-31 2026 Q1 10-Q 2025-12-11 0001493152-25-027240
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 34.71M 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap ProceedsFromRepaymentsOfRelatedPartyDebt Proceeds from (Repayments of) Related Party Debt USD 175,000 2023-12-20 2024 FY 10-K 2024-10-29 0001493152-24-042743
us-gaap ProceedsFromRepurchaseOfEquity Proceeds from (Repurchase of) Equity USD 1.61M 2020-08-01 2021-07-31 2022 FY 10-K 2022-10-28 0001493152-22-029742
us-gaap ProceedsFromSaleOfShortTermInvestments Proceeds from Sale of Short-term Investments USD 21.29M 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 821,015 2024-08-01 2025-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap ProfessionalFees Professional Fees USD 1.21M 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -35.33M 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap PropertyPlantAndEquipmentAdditions Property, Plant and Equipment, Additions USD 127,049 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 456,801 2024-07-31 2025 FY 10-K 2025-10-16 0001493152-25-018212
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 319,804 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap RepaymentsOfShortTermDebt Repayments of Short-term Debt USD 239,000 2020-08-01 2021-07-31 2022 FY 10-K 2022-10-28 0001493152-22-029742
us-gaap RepaymentsOfUnsecuredDebt Repayments of Unsecured Debt USD 307,108 2020-08-01 2021-07-31 2022 FY 10-K 2022-10-28 0001493152-22-029742
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 29.24M 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -146.66M 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap SalariesAndWages Salary and Wage, NonOfficer, Excluding Cost of Good and Service Sold USD 1.75M 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 1.13M 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price USD/shares 6.19 2021-06-03 2022 FY 10-K 2022-10-28 0001493152-22-029742
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-08-01 2026-04-30 2026 Q3 10-Q 2026-06-09 0001493152-26-027928
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 1 2021-04-11 2021-04-12 2025 FY 10-K 2025-10-16 0001493152-25-018212
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.041 2024-08-01 2025-07-31 2026 Q3 10-Q 2026-06-09 0001493152-26-027928
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Period Increase (Decrease), Weighted Average Exercise Price USD/shares 5.68 2021-08-01 2022-07-31 2022 FY 10-K 2022-10-28 0001493152-22-029742
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 796.88 2021-04-11 2021-04-12 2025 FY 10-K 2025-10-16 0001493152-25-018212
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable shares 63,690 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding shares 335,332 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap SharePrice Share Price USD/shares 4.18 2026-04-30 2026 Q3 10-Q 2026-06-09 0001493152-26-027928
us-gaap ShortTermInvestments Short-term Investments USD 10.69M 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -3.78M 2023-07-31 2023 FY 10-K 2023-10-25 0001493152-23-038298
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 15.56M 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap StockIssued1 Stock Issued USD 329,670 2020-08-01 2021-07-31 2022 FY 10-K 2022-10-28 0001493152-22-029742
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 0 2025-08-01 2025-10-31 2026 Q1 10-Q 2025-12-11 0001493152-25-027240
us-gaap StockIssuedDuringPeriodSharesShareBasedCompensationForfeited Shares Issued, Shares, Share-based Payment Arrangement, Forfeited shares 667,366 2022-02-01 2022-04-30 2023 Q3 10-Q 2023-06-14 0001493152-23-021287
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 301,600 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 329,670 2020-08-01 2021-07-31 2022 FY 10-K 2022-10-28 0001493152-22-029742
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 31.81M 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 13.61M 2020-08-01 2021-07-31 2022 FY 10-K 2022-10-28 0001493152-22-029742
us-gaap StockIssuedDuringPeriodValueShareBasedCompensationGross Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture USD 5.59M 2022-02-01 2022-04-30 2023 Q3 10-Q 2023-06-14 0001493152-23-021287
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 377,000 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 9.10M 2021-08-01 2022-07-31 2023 FY 10-K 2023-10-25 0001493152-23-038298
us-gaap TaxesExcludingIncomeAndExciseTaxes Taxes, Miscellaneous USD 965,764 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD 14,804 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2024-07-31 2025 FY 10-K 2025-10-16 0001493152-25-018212
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 1.79M 2023-08-01 2024-07-31 2024 FY 10-K 2024-10-29 0001493152-24-042743
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 5.01M 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 5.01M 2025-08-01 2026-07-31 2026 FY 10-K 2026-10-28 0001493152-26-049041

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →